K Logo (EUIPO, 03/13/2023)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark K was filed as Figurative mark on 03/13/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/30/2023.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Lines or bands forming an angle #One letter #Letter 'K' #Blue
| Trademark form | Figurative mark |
| File reference | 018847577 |
| Application date | March 13, 2023 |
| Publication date | May 23, 2023 |
| Entry date | August 30, 2023 |
| Expiration date | March 13, 2033 |
Trademark owner
103 Montgomery Street, suite 150 The Presidio of San Francisco
94129 San Francisco
US
94129 San Francisco
US
Trademark representatives
Pilestræde 58
1112 Copenhagen K
DK
goods and services
5
Therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; dermatological pharmaceutical preparations; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical and medical preparations; anticancer preparations; antitumor drugs; vaccines; anticancer vaccines; peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs for medical purposes; biological preparations for medical; cellular preparations for medical purposes; biological tissue for implantation; radiopharmaceutical preparations for diagnostic, medical use; pharmaceutical preparations for the treatment of autoimmune diseases and infectious diseases; clinical diagnostic reagents; diagnostic agents, preparations and test kits for medical purposes; drug delivery agents; adjuvants for medical use; dietetic substances adapted for medical use
42
scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; scientific and technological services, research and design relating thereto; industrial analysis and research services; scientific research for medical purposes; scientific research and development for medical purposes in the area of cancerous diseases, autoimmune diseases or infectious diseases; drug development services; conducting clinical trials for others; preclinical and clinical research; analysis of toxicology and mode of action of biologicals, chemicals and combinations on humans; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes; computer-aided diagnostic testing services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management
44
Medical services; medical diagnostic services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 5, 2023 | Transfer / Change of address, Registered |
ID: 11018847577